Spending power
TheGrid Corporate Spending Power index would rate purchasing capacity from registry, scale and activity signals.
Spending power
Brand profile · Biotechnology Research
Endo Axiom works in Biotechnology Research, out of Haymarket, NSW. Privately held, at endoaxiom.com. It holds one address on record, all in Australia. It employs 3 people, on the record. One Australian registration (ABN) is a confirmed match. The latest round on record is Grant at US$698.3K. The record links eight similar brands, most of them in Biotechnology Research.
ABN28665402326
| ENDO AXIOM PTY LTD | ABN 28665402326 |
|---|---|
| Confirmed matches | 0 of 1 |
A candidate is a name match on the registry, not a confirmed identity, and two candidates are ambiguity rather than a corporate structure.
Endo Axiom is focused on prevention of autoimmune diseases and improving the quality of life of diabetics. We develop biotechnology platforms for the oral delivery of drug and biologics and take these to clinical validation.
| Countries | 1 |
|---|---|
| Primary country | AU |
All codes: AU
| Rounds | 1 |
|---|---|
| Axis | 2023 to 2026 |
| Grant · 20 Jul 2025 | US$ 698.3K |
Dated rounds only. The axis ends at the date this profile was last observed, not at today.
TheGrid Corporate Spending Power index would rate purchasing capacity from registry, scale and activity signals.
Spending power
Hiring, headcount and registry-change signals, streamed to members.
Registry-filed capital and financial indicators, standardised by TheGrid.
2 employee profiles on record · names withheld.
Names and titles are intentionally absent from this page. The source relation carries no consent record across the privacy regimes this directory spans, so it is never requested and never stored. Search engines see exactly what you see here.
The people relation is never requested, so there is nothing here to unlock.
One New South Wales entity on the ABR: ENDO AXIOM PTY LTD (ABN 28 665 402 326), high confidence.
3 counted staff profiles at January 2026, inside the self-reported 2–10 band.
One address on record, Australia only. Primary: Haymarket, NSW.
One round. Latest 20 July 2025: grant, US$698,300, investor MTPConnect.
16 profiles list Endo Axiom as a peer — 90th percentile in Biotechnology Research. It lists ten peers of its own. ASK Scientia Pty Ltd and Anaxis Pharma list it back.